Chester County News and Community Website
PHILADELPHIA, PA — Passage Bio, Inc. (NASDAQ: PASG) announced its management will take part in two upcoming investor conferences in mid-August.
Passage Bio to Participate in Upcoming Investor Conferences Read More PHILADELPHIA, PA — Passage Bio, Inc. (NASDAQ: PASG) has announced a series of agreements to out-license its three clinical-stage pediatric lysosomal storage disease programs to GEMMA Biotherapeutics, Inc. (GEMMABio). The …
Passage Bio Out-Licenses Rare Disease Programs to GEMMA Biotherapeutics Read More PHILADELPHIA, PA — Passage Bio, Inc. (NASDAQ: PASG) announced positive feedback from the U.S. Food and Drug Administration (FDA) on its proposal to evaluate PBFT02 for treating frontotemporal dementia (FTD) …
Passage Bio Receives FDA Support for Expanding Dementia Treatment Trial Read More PHILADELPHIA, PA — Passage Bio, Inc. (NASDAQ: PASG) announced that its president and CEO, William Chou, M.D., will present at the Goldman Sachs 45th Annual Global Healthcare Conference. Dr. Chou’s …
Passage Bio CEO to Present at Goldman Sachs Global Healthcare Conference Read More PHILADELPHIA, PA — Passage Bio, Inc. has awarded its third annual Tachi Yamada Scholarship to Carrie Gordon, a sophomore at Drexel University. This scholarship honors Dr. Tachi Yamada, co-founder and …
Drexel Student Awarded Tachi Yamada Scholarship by Passage Bio Read More PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) recently shared its first-quarter financials and highlighted recent advancements in its clinical trials. Among the key updates, interim data from its upliFT-D …
Passage Bio Reports Promising Interim Data in FTD-GRN Treatment Trial Read More